CD274 and head and neck squamous cell carcinoma: However, the combination of radiotherapy with inhibition of programmed cell death protein (PD-1) or its ligand 1 (PD-L1) has not proven to be effective yet for HNSCC patients and several trials are currently ongoing [4–8].